The Royal Danish Embassy in Washington DC, USA, is hosting the first of a series of US-Danish Biomedical Innovation and Health Meetings from 8-10 September in Boston, MA and Washington DC. The aim is to strengthen the relationship and collaboration between biomedical regions in the US and Denmark, writes financial daily newspaper Børsen.
Health consultant at the Danish Embassy in Washington, Joakim Steen Mikkelsen told Børsen: "With this initiative, we want to create a platform with unique competences and resources that give Danes access to both networks and development."
The guest list comprises representatives from universities, development centres and Danish companies including Coloplast, Novo Nordisk and Dako.
The bio-innovation days are not only intended for Danish companies. The US part of the industry is also showing curiosity regarding Danish scientific and commercial competences, which will be presented at the meetings.
The objectives of the first meetings include: enhancing biomedical innovation and productivity through showcasing of successful innovation models, establishing lasting and mutually beneficial collaboration between the biomedical clusters in Massachusetts and Denmark/Medicon Valley and to facilitate a forum in Washington DC to discuss ways that the US and Denmark can structure health regulation and policies to make healthcare better, cheaper and more accessible to consumers.